Analystreport

Cancer Genetics, Inc. (NASDAQ: CGIX) was downgraded by analysts at Dawson James from a "buy" rating to a "neutral" rating.

CANCER GENETICS  (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com